Regeneron Pharmaceuticals Inc (REGN)
957.00
+19.39
(+2.07%)
USD |
NASDAQ |
May 03, 16:00
956.28
-0.72
(-0.08%)
After-Hours: 20:00
Regeneron Pharmaceuticals Cash from Investing (Quarterly): -1.687B for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.687B |
December 31, 2023 | -66.20M |
September 30, 2023 | -496.30M |
June 30, 2023 | -2.387B |
March 31, 2023 | -235.70M |
December 31, 2022 | -1.858B |
September 30, 2022 | 192.30M |
June 30, 2022 | -413.90M |
March 31, 2022 | -1.705B |
December 31, 2021 | -2.013B |
September 30, 2021 | -2.439B |
June 30, 2021 | 125.80M |
March 31, 2021 | -1.059B |
December 31, 2020 | -305.00M |
September 30, 2020 | -775.80M |
June 30, 2020 | 1.453B |
March 31, 2020 | -443.20M |
December 31, 2019 | -208.70M |
September 30, 2019 | -207.00M |
June 30, 2019 | -836.00M |
March 31, 2019 | -776.10M |
December 31, 2018 | -265.90M |
September 30, 2018 | -286.70M |
June 30, 2018 | -485.00M |
March 31, 2018 | -425.40M |
Date | Value |
---|---|
December 31, 2017 | -335.76M |
September 30, 2017 | -358.88M |
June 30, 2017 | -170.41M |
March 31, 2017 | -140.14M |
December 31, 2016 | -271.25M |
September 30, 2016 | -405.85M |
June 30, 2016 | -326.01M |
March 31, 2016 | -43.68M |
December 31, 2015 | -123.30M |
September 30, 2015 | -283.17M |
June 30, 2015 | -371.65M |
March 31, 2015 | -129.48M |
December 31, 2014 | 56.64M |
September 30, 2014 | -123.07M |
June 30, 2014 | -118.12M |
March 31, 2014 | -236.23M |
December 31, 2013 | -109.95M |
September 30, 2013 | -214.45M |
June 30, 2013 | 116.63M |
March 31, 2013 | -147.68M |
December 31, 2012 | 91.10M |
September 30, 2012 | -48.75M |
June 30, 2012 | -139.19M |
March 31, 2012 | 15.77M |
December 31, 2011 | -33.91M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.439B
Minimum
Sep 2021
1.453B
Maximum
Jun 2020
-768.19M
Average
-469.75M
Median
Cash from Investing (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | -886.50M |
Amgen Inc | -217.00M |
Eli Lilly and Co | -1.178B |
Moderna Inc | 118.00M |
Gilead Sciences Inc | -2.207B |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 1.512B |
Cash from Financing (Quarterly) | 47.10M |
Free Cash Flow | 3.930B |
Free Cash Flow Per Share (Quarterly) | 11.74 |
Free Cash Flow to Equity (Quarterly) | 1.350B |
Free Cash Flow to Firm (Quarterly) | 1.351B |
Free Cash Flow Yield | 3.60% |